Home / GLP-1 appeals / Denial reasons / Step therapy

Denial reason · Step therapy

Your GLP-1 was denied for step therapy. Here is how to appeal it.

A step therapy or fail-first denial is not a verdict on whether the medication is right for you. It is your plan asking you to try other drugs first. If you already did, or they are not safe for you, that is the heart of a winnable appeal. We draft it for free, grounded in your plan's own rules with every citation verified. You review, sign, and file it.

Check my denial, free See the strategy

Free to draft. Every citation checked against your plan's policy before you file.

Your deadline

Often 60 to 180 days

For your plan's first internal appeal. Your denial notice states the exact window, check it.

What triggers it

A required drug first

Your plan wants a documented trial of a preferred or lower-cost option before it covers this one.

What wins

Show you already stepped

Proof of a prior trial, intolerance, or contraindication maps straight to the override the plan already allows.

What a step therapy denial means for a GLP-1

Step therapy, also called fail-first, is a cost-control rule. Before your plan will cover the GLP-1 your prescriber chose, it wants you to try, and not succeed on, one or more drugs it prefers. The denial is procedural: it is about the order of treatment, not whether the medication is appropriate for you. This pattern shows up across the GLP-1 class:

  • Wegovy and Zepbound (weight management). Wegovy (semaglutide 2.4 mg) and Zepbound (tirzepatide) are FDA-approved for chronic weight management. Plans often require a documented trial of lifestyle programs or older anti-obesity medications first, and sometimes one branded GLP-1 before another.
  • Ozempic and Mounjaro (type 2 diabetes). Ozempic (semaglutide) and Mounjaro (tirzepatide) are FDA-approved for type 2 diabetes. Plans commonly require metformin, and sometimes a second oral agent, before covering an injectable GLP-1.
  • The trial happened but was not recorded. A very common reason: you did try the preferred drug, but the documentation submitted with the claim did not show it clearly. The plan denies for a step you actually completed.
  • The preferred drug is not safe or appropriate for you. Most plans have a documented exception path when the required drug is contraindicated, was previously not tolerated, or is expected to be ineffective for your situation.

How to win a step therapy appeal

Step therapy is one of the more winnable denial types, because plans publish the exact conditions under which they will skip the step. The job is to show, plainly, that you meet one of them.

The move: find your plan's step therapy exception criteria, then point at the one that fits you, prior trial, intolerance, contraindication, or expected ineffectiveness, and attach the dated record that proves it. You are not arguing the rule is wrong. You are showing you already satisfy the plan's own escape hatch.

  • Document the prior trial precisely: the drug name, the dates you took it, and what happened, lack of effect, side effects, or a medical reason you had to stop.
  • Cite the exception, not just medical necessity. Name the specific step therapy override your plan publishes and answer its conditions in order. Many states also have step therapy override laws that set firm response deadlines.
  • Add a letter of medical necessity from your prescriber explaining why the preferred drug is not the right first step for you. The clinical opinion comes from your clinician, not from us.
  • File within the window, then escalate. Under the Affordable Care Act you have the right to a full internal appeal and, if it is upheld, an independent external review by a reviewer not employed by your plan.

Sources include your plan's published step therapy and formulary policy and the FDA prescribing information for your medication. We cite the specific policy that applies to your plan when we build your appeal.

The magic is visible

Your appeal, built from your plan's own rules. Every citation checked.

We draft from the sources below, then verify each one before you file. On our held-out testing: 0 invented citations, versus about 1 in 4 for raw AI.

Sample appeal, built from real source types

  • Your plan's coverage policyYour plan's published step therapy and formulary rules for GLP-1 medicationsVerified
  • FDA labelThe prescribing information for your GLP-1, indication and dosingVerified
  • Your recordsYour prior drug trials, intolerances, and contraindications, cited back accuratelyVerified

Let's check your step therapy denial, free.

Answer a few questions for an honest read on your odds, then your verified draft. No account, no cost.

Check my denial, free

Step therapy denials: common questions

What does step therapy actually require?
It requires you to try, and not succeed on, one or more preferred or lower-cost drugs before your plan covers the one your prescriber chose. It is about the order of treatment, not whether the medication is appropriate for you.
I already tried the other drug. Why was I still denied?
Often the trial happened but the records submitted did not show it clearly. Documenting the drug name, the dates, and the outcome, lack of effect, side effects, or a medical reason you stopped, is usually the fastest path to a reversal.
What if the preferred drug is not safe for me?
Most plans publish a step therapy exception for drugs that are contraindicated, previously not tolerated, or expected to be ineffective. A letter of medical necessity from your prescriber, paired with the records, is how you claim it. The clinical opinion comes from your clinician.
Is this really free?
Yes. We draft your appeal for free and you file it. No fee, no contingency, nothing taken from coverage you win. AppealIt is not a law firm and does not provide legal or medical advice.

By drug: Wegovy · Zepbound · Ozempic · Mounjaro · By payer: Aetna · Cigna